EDITORIAL
Published on 13 Dec 2022
Editorial: Women in head and neck cancer 2021
doi 10.3389/fonc.2022.1024210
- 816 views
- Frontiers in Oncology
- Head and Neck Cancer
- Research Topics
- Women in Head and Neck Cancer: 2021
Women in Head and Neck Cancer: 2021
19k
Total Downloads
63k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 22 Apr 2022
Prevalence of Transcriptionally Active HPV Infection in Tumor-Free Oropharyngeal Tissue of OPSCC-Patients
doi 10.3389/fonc.2022.835814
- 1,087 views
- 2 citations
ORIGINAL RESEARCH
Published on 09 Feb 2022
miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands
doi 10.3389/fonc.2021.786150
- 2,774 views
- 12 citations
ORIGINAL RESEARCH
Published on 24 Jan 2022
Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain
doi 10.3389/fonc.2021.747520
- 1,808 views
CASE REPORT
Published on 10 Jan 2022
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
doi 10.3389/fonc.2021.799453
- 2,432 views
- 5 citations
ORIGINAL RESEARCH
Published on 13 Dec 2021
Leukoplakia: An Invasive Cancer Hidden within the Vocal Folds. A Multivariate Analysis of Risk Factors
doi 10.3389/fonc.2021.772255
- 10,625 views
- 6 citations
PERSPECTIVE
Published on 18 Nov 2021
When Everything Revolves Around Internal Carotid Artery: Analysis of Different Management Strategies in Patients With Very Advanced Cancer Involving the Skull Base
doi 10.3389/fonc.2021.781205
- 5,044 views
- 1 citation
ORIGINAL RESEARCH
Published on 10 Nov 2021
TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
doi 10.3389/fonc.2021.782658
- 2,412 views
- 8 citations
ORIGINAL RESEARCH
Published on 27 Oct 2021
Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients
doi 10.3389/fonc.2021.714551
- 5,827 views
- 6 citations
ORIGINAL RESEARCH
Published on 24 Sep 2021
Rehabilitation Needs of Head and Neck Cancer Patients and Stakeholders: Case Study
doi 10.3389/fonc.2021.670790
- 4,044 views
- 3 citations
ORIGINAL RESEARCH
Published on 10 Sep 2021
The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy
doi 10.3389/fonc.2021.697967
- 1,762 views
- 14 citations
ORIGINAL RESEARCH
Published on 20 Jul 2021
Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
doi 10.3389/fonc.2021.715297
- 2,532 views
Published in
Frontiers in Oncology
- Head and Neck Cancer
Impact
- 63kTopic views
- 43kArticle views
- 19kArticle downloads